Is Heparin Sodium Injection in shortage?
Yes. Heparin Sodium Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)
Maker contact: 888-229-0001
- Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)
Maker contact: 888-229-0001
- Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)
Estimated recovery: late Q4 2026; Manufacturing delays
Maker contact: 800-227-2862
- Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)
Estimated recovery: late Q4 2026; Manufacturing delays
Maker contact: 800-227-2862
- Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20)
Maker contact: 844-646-4398
- Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)
Maker contact: 844-646-4398
- Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)
Next release September 2026. Check wholesalers for inventory.
Maker contact: 888-386-1300
FDA recalls of Heparin Sodium
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Heparin Sodium Injection:
- Baxter Healthcare Corporation recalls Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile
- B. Braun Medical Inc recalls Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B.
- B. Braun Medical Inc recalls Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container,
- Sagent Pharmaceuticals Inc recalls Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or
- Pfizer Inc. recalls Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a)
- B. Braun Medical Inc recalls Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag,
- Baxter Healthcare Corp recalls Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only,
- Baxter Healthcare Corp. recalls Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only,
- Hospira Inc. recalls HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL
- Hospira Inc. recalls Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL,
- Fresenius Kabi USA, LLC recalls Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx
- Hospira Inc. recalls Heparin Sodium 2000 USP Heparin Units per 1000 mL (2 USP Heparin Units/mL) in 0.9% Sodium Chloride Injection, Rx only.
Heparin Sodium Injection shortage questions
Is Heparin Sodium Injection in shortage?
Yes. Heparin Sodium Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Heparin Sodium Injection shortage?
FDA records the reason as: Other.
What should I do if I can’t get Heparin Sodium Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.